Lipoic acid stimulates cAMP production via the EP2 and EP4 prostanoid receptors and inhibits IFN gamma synthesis and cellular cytotoxicity in NK cells
- 13 August 2008
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 199 (1-2) , 46-55
- https://doi.org/10.1016/j.jneuroim.2008.05.003
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetesNature, 2007
- Expansion of CD56Bright natural killer cells in the peripheral blood of multiple sclerosis patients treated with interferon-betaNeurological Sciences, 2007
- Regulation of Activated CD4+ T Cells by NK Cells via the Qa-1–NKG2A Inhibitory PathwayImmunity, 2007
- Myocardial Phosphodiesterases and Regulation of Cardiac Contractility in Health and Cardiac DiseaseCardiovascular Drugs and Therapy, 2007
- α-Lipoic acid attenuates LPS-induced inflammatory responses by activating the phosphoinositide 3-kinase/Akt signaling pathwayProceedings of the National Academy of Sciences, 2007
- Lipoic acid stimulates cAMP production in T lymphocytes and NK cellsBiochemical and Biophysical Research Communications, 2007
- Involvement of EP1 and EP2 receptors in the regulation of the Na,K-ATPase by prostaglandins in MDCK cellsProstaglandins & Other Lipid Mediators, 2006
- Prostaglandin E2 is a potent regulator of interleukin‐12‐ and interleukin‐18‐induced natural killer cell interferon‐γ synthesisImmunology, 2004
- Multiple diverse ligands binding at a single protein site: A matter of pre‐existing populationsProtein Science, 2002
- Convergent Solutions to Binding at a Protein-Protein InterfaceScience, 2000